{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T16:14:50Z","timestamp":1723565690627},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s00393-023-01454-y","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T14:02:06Z","timestamp":1703858526000},"page":"41-51","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fortschritte in der Diagnostik und Therapie der juvenilen Dermatomyositis","Advances in the diagnostics and treatment of juvenile dermatomyositis"],"prefix":"10.1007","volume":"83","author":[{"given":"Ingrid","family":"Georgi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Georgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes-Peter","family":"Haas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,29]]},"reference":[{"key":"1454_CR1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/rheumatology\/kew396","volume":"56","author":"R Aggarwal","year":"2017","unstructured":"Aggarwal\u00a0R, Loganathan\u00a0P, Koontz\u00a0D et\u00a0al (2017) Cutaneous improvement in refractory adult and juvenile dermatomyositis after treatment with rituximab. Rheumatol (Oxford) 56:247\u2013254","journal-title":"Rheumatol (Oxford)"},{"key":"1454_CR2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1159\/000166859","volume":"4","author":"Anonymous","year":"1984","unstructured":"Anonymous (1984) Renal pathology forum. Am J Nephrol 4:383\u2013390","journal-title":"Am J Nephrol"},{"key":"1454_CR3","first-page":"51","volume":"53","author":"LC Archard","year":"1987","unstructured":"Archard\u00a0LC, Richardson\u00a0PJ, Olsen\u00a0EG et\u00a0al (1987) The role of coxsackie B viruses in the pathogenesis of myocarditis, dilated cardiomyopathy and inflammatory muscle disease. Biochem Soc Symp 53:51\u201362","journal-title":"Biochem Soc Symp"},{"key":"1454_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12969-021-00646-7","volume":"19","author":"C Astley","year":"2021","unstructured":"Astley\u00a0C, Sieczkowska\u00a0SM, Marques\u00a0IG et al (2021) Home-based exercise program for adolescents with juvenile dermatomyositis quarantined during COVID-19 pandemic: a\u00a0mixed methods study. Pediatr Rheumatol Online\u00a0J 19:159","journal-title":"Pediatr Rheumatol Online J"},{"key":"1454_CR5","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1002\/art.38038","volume":"65","author":"I Balboni","year":"2013","unstructured":"Balboni\u00a0I, Niewold\u00a0TB, Morgan\u00a0G et al (2013) Interferon-alpha induction and detection of anti-ro, anti-la, anti-sm, and anti-rnp autoantibodies by autoantigen microarray analysis in juvenile dermatomyositis. Arthritis Rheum 65:2424\u20132429","journal-title":"Arthritis Rheum"},{"key":"1454_CR6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan\u00a0A, Peter\u00a0JB (1975) Polymyositis and dermatomyositis (first of two parts). N\u00a0Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"1454_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan\u00a0A, Peter\u00a0JB (1975) Polymyositis and dermatomyositis (second of two parts). N\u00a0Engl J Med 292:403\u2013407","journal-title":"N Engl J Med"},{"key":"1454_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0009-9260(96)80278-9","volume":"51","author":"AL Brown","year":"1996","unstructured":"Brown\u00a0AL, Murray\u00a0JG, Robinson\u00a0SP et\u00a0al (1996) Case report: milk of calcium complicating juvenile dermatomyositis\u2014imaging features. Clin Radiol 51:147\u2013149","journal-title":"Clin Radiol"},{"key":"1454_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.pediatrneurol.2021.07.017","volume":"124","author":"AM Cappellari","year":"2021","unstructured":"Cappellari\u00a0AM, Minoia\u00a0F, Consonni\u00a0D et al (2021) Development and preliminary validation of an electromyography-scoring protocol for the assessment and grading of muscle involvement in patients with juvenile idiopathic inflammatory myopathies. Pediatr Neurol 124:6\u201310","journal-title":"Pediatr Neurol"},{"key":"1454_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.31138\/mjr.33.1.63","volume":"33","author":"R Chatterjee","year":"2022","unstructured":"Chatterjee\u00a0R, Mehta\u00a0P, Agarwal\u00a0V et\u00a0al (2022) Genetics and autoimmunity: two sides of the same coin or an epiphenomenon? Mediterr J Rheumatol 33:63\u201367","journal-title":"Mediterr J Rheumatol"},{"key":"1454_CR11","doi-asserted-by":"crossref","unstructured":"Cheng I, Wong CS (2023) A systematic review and meta-analysis on the prevalence and clinical characteristics of dysphagia in patients with dermatomyositis. Neurogastroenterol Motil e14572:","DOI":"10.1111\/nmo.14572"},{"key":"1454_CR12","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1093\/rheumatology\/ker379","volume":"51","author":"H Chinoy","year":"2012","unstructured":"Chinoy\u00a0H, Li\u00a0CK, Platt\u00a0H et al (2012) Genetic association study of NF-kappaB genes in UK caucasian adult and juvenile onset idiopathic inflammatory myopathy. Rheumatol (Oxford) 51:794\u2013799","journal-title":"Rheumatol (Oxford)"},{"key":"1454_CR13","doi-asserted-by":"crossref","unstructured":"Covert LT, Patel H, Osman A et\u00a0al (2023) Effect of type\u00a0I interferon on engineered pediatric skeletal muscle: a\u00a0promising model for juvenile dermatomyositis. Rheumatol (Oxford)","DOI":"10.1093\/rheumatology\/kead186"},{"key":"1454_CR14","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00296-010-1653-5","volume":"32","author":"R Dagher","year":"2012","unstructured":"Dagher\u00a0R, Desjonqueres\u00a0M, Duquesne\u00a0A et\u00a0al (2012) Mycophenolate mofetil in juvenile dermatomyositis: a\u00a0case series. Rheumatol Int 32:711\u2013716","journal-title":"Rheumatol Int"},{"key":"1454_CR15","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1093\/rheumatology\/ker262","volume":"50","author":"WR Davis","year":"2011","unstructured":"Davis\u00a0WR, Halls\u00a0JE, Offiah\u00a0AC et al (2011) Assessment of active inflammation in juvenile dermatomyositis: a\u00a0novel magnetic resonance imaging-based scoring system. Rheumatol (Oxford) 50:2237\u20132244","journal-title":"Rheumatol (Oxford)"},{"key":"1454_CR16","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1093\/hmg\/ddac019","volume":"31","author":"CT Deakin","year":"2022","unstructured":"Deakin\u00a0CT, Bowes\u00a0J, Rider\u00a0LG et al (2022) Association with HLA-DRbeta1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositis. Hum Mol Genet 31:2471\u20132481","journal-title":"Hum Mol Genet"},{"key":"1454_CR17","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1055\/s-0031-1273723","volume":"223","author":"F Dressler","year":"2011","unstructured":"Dressler\u00a0F, Frosch\u00a0M, Monkemoller\u00a0K et al (2011) Results of the German ESPED-recording of new patients with juvenile dermatomyositis (JDM). Klin Padiatr 223:280\u2013282","journal-title":"Klin Padiatr"},{"key":"1454_CR18","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1590\/S1677-55382006000500013","volume":"32","author":"RJ Duarte","year":"2006","unstructured":"Duarte\u00a0RJ, Denes\u00a0FT, Sallum\u00a0AM (2006) Ureteral calcinosis in juvenile dermatomyositis: successful precocious surgical management. Int Braz J Urol 32:574\u2013577","journal-title":"Int Braz J Urol"},{"key":"1454_CR19","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/art.41078","volume":"72","author":"B Duvvuri","year":"2020","unstructured":"Duvvuri\u00a0B, Pachman\u00a0LM, Morgan\u00a0G et\u00a0al (2020) Neutrophil extracellular traps in tissue and periphery in juvenile dermatomyositis. Arthritis Rheumatol 72:348\u2013358","journal-title":"Arthritis Rheumatol"},{"key":"1454_CR20","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/1756-185X.14152","volume":"24","author":"RK Elnaggar","year":"2021","unstructured":"Elnaggar\u00a0RK, El-Nabie\u00a0AWA (2021) Efficacy of aqua-based plyometric exercises in the rehabilitation of patients with juvenile dermatomyositis: a\u00a0randomized crossover pilot study. Int J Rheum Dis 24:930\u2013940","journal-title":"Int J Rheum Dis"},{"key":"1454_CR21","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/annrheumdis-2016-209247","volume":"76","author":"FB Enders","year":"2017","unstructured":"Enders\u00a0FB, Bader-Meunier\u00a0B, Baildam\u00a0E et al (2017) Consensus-based recommendations for the management of juvenile dermatomyositis. Ann Rheum Dis 76:329\u2013340","journal-title":"Ann Rheum Dis"},{"key":"1454_CR22","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","volume":"371","author":"BM Feldman","year":"2008","unstructured":"Feldman\u00a0BM, Rider\u00a0LG, Reed\u00a0AM et\u00a0al (2008) Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 371:2201\u20132212","journal-title":"Lancet"},{"key":"1454_CR23","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/BOR.0000000000000831","volume":"33","author":"C Franco","year":"2021","unstructured":"Franco\u00a0C, Gatto\u00a0M, Iaccarino\u00a0L et\u00a0al (2021) Lymphocyte immunophenotyping in inflammatory myositis: a\u00a0review. Curr Opin Rheumatol 33:522\u2013528","journal-title":"Curr Opin Rheumatol"},{"key":"1454_CR24","doi-asserted-by":"crossref","unstructured":"Gibbs E, Khojah A, Morgan G et\u00a0al (2023) The von willebrand factor antigen reflects the juvenile dermatomyositis disease activity score. Biomedicines 11:","DOI":"10.3390\/biomedicines11020552"},{"key":"1454_CR25","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s10067-008-0973-2","volume":"27","author":"J Hassan","year":"2008","unstructured":"Hassan\u00a0J, Van Der Net\u00a0JJ, Van Royen-Kerkhof\u00a0A (2008) Treatment of refractory juvenile dermatomyositis with tacrolimus. Clin Rheumatol 27:1469\u20131471","journal-title":"Clin Rheumatol"},{"key":"1454_CR26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12969-018-0257-6","volume":"16","author":"CH Hinze","year":"2018","unstructured":"Hinze\u00a0CH, Oommen\u00a0PT, Dressler\u00a0F et al (2018) Development of practice and consensus-based strategies including a\u00a0treat-to-target approach for the management of moderate and severe juvenile dermatomyositis in Germany and Austria. Pediatr Rheumatol Online\u00a0J 16:40","journal-title":"Pediatr Rheumatol Online J"},{"key":"1454_CR27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12969-018-0256-7","volume":"16","author":"CH Hinze","year":"2018","unstructured":"Hinze\u00a0CH, Speth\u00a0F, Oommen\u00a0PT et\u00a0al (2018) Current management of juvenile dermatomyositis in Germany and Austria: an online survey of pediatric rheumatologists and pediatric neurologists. Pediatr Rheumatol Online\u00a0J 16:38","journal-title":"Pediatr Rheumatol Online J"},{"key":"1454_CR28","doi-asserted-by":"publisher","first-page":"433","DOI":"10.55563\/clinexprheumatol\/94btoy","volume":"40","author":"S Horn","year":"2022","unstructured":"Horn\u00a0S, Minden\u00a0K, Speth\u00a0F et al (2022) Myositis-specific autoantibodies and their associated phenotypes in juvenile dermatomyositis: data from a\u00a0German cohort. Clin Exp Rheumatol 40:433\u2013442","journal-title":"Clin Exp Rheumatol"},{"key":"1454_CR29","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/rheumatology\/keac399","volume":"62","author":"B Huang","year":"2023","unstructured":"Huang\u00a0B, Wang\u00a0X, Niu\u00a0Y et al (2023) Long-term follow-up of Janus-kinase inhibitor and novel active disease biomarker in juvenile dermatomyositis. Rheumatol (Oxford) 62:1227\u20131237","journal-title":"Rheumatol (Oxford)"},{"issue":"4","key":"1454_CR30","first-page":"114","volume":"29","author":"NH Huang","year":"2020","unstructured":"Huang\u00a0NH, Lien\u00a0LM, Chen\u00a0WH (2020) Macrophage activation syndrome in a\u00a0case of myasthenia gravis with concurrent cytomegalovirus infection. Acta Neurol Taiwan 29(4):114\u2013118","journal-title":"Acta Neurol Taiwan"},{"key":"1454_CR31","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1093\/rheumatology\/kem179","volume":"46","author":"AM Huber","year":"2007","unstructured":"Huber\u00a0AM, Dugan\u00a0EM, Lachenbruch\u00a0PA et\u00a0al (2007) The cutaneous assessment tool: development and reliability in juvenile idiopathic inflammatory myopathy. Rheumatol (Oxford) 46:1606\u20131611","journal-title":"Rheumatol (Oxford)"},{"key":"1454_CR32","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/art.23340","volume":"59","author":"AM Huber","year":"2008","unstructured":"Huber\u00a0AM, Dugan\u00a0EM, Lachenbruch\u00a0PA et\u00a0al (2008) Preliminary validation and clinical meaning of the cutaneous assessment tool in juvenile dermatomyositis. Arthritis Rheum 59:214\u2013221","journal-title":"Arthritis Rheum"},{"key":"1454_CR33","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/art.20179","volume":"50","author":"AM Huber","year":"2004","unstructured":"Huber\u00a0AM, Feldman\u00a0BM, Rennebohm\u00a0RM et\u00a0al (2004) Validation and clinical significance of the childhood Myositis assessment scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum 50:1595\u20131603","journal-title":"Arthritis Rheum"},{"key":"1454_CR34","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/acr.20695","volume":"64","author":"AM Huber","year":"2012","unstructured":"Huber\u00a0AM, Robinson\u00a0AB, Reed\u00a0AM et\u00a0al (2012) Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second childhood arthritis and rheumatology research alliance consensus conference. Arthritis Care Res (Hoboken) 64:546\u2013553","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1454_CR35","first-page":"610","volume":"28","author":"C Huemer","year":"2001","unstructured":"Huemer\u00a0C, Kitson\u00a0H, Malleson\u00a0PN et\u00a0al (2001) Lipodystrophy in patients with juvenile dermatomyositis\u2014evaluation of clinical and metabolic abnormalities. J\u00a0Rheumatol 28:610\u2013615","journal-title":"J Rheumatol"},{"key":"1454_CR36","doi-asserted-by":"crossref","unstructured":"Khojah A, Morgan G, Pachman LM (2021) Clues to disease activity in juvenile dermatomyositis: neopterin and other biomarkers. Diagnostics (Basel) 12:","DOI":"10.3390\/diagnostics12010008"},{"key":"1454_CR37","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/BOR.0000000000000816","volume":"33","author":"H Kim","year":"2021","unstructured":"Kim\u00a0H (2021) Updates on interferon in juvenile dermatomyositis: pathogenesis and therapy. Curr Opin Rheumatol 33:371\u2013377","journal-title":"Curr Opin Rheumatol"},{"key":"1454_CR38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13075-020-02160-9","volume":"22","author":"H Kim","year":"2020","unstructured":"Kim\u00a0H, Gunter-Rahman\u00a0F, Mcgrath\u00a0JA et al (2020) Expression of interferon-regulated genes in juvenile dermatomyositis versus mendelian autoinflammatory interferonopathies. Arthritis Res Ther 22:69","journal-title":"Arthritis Res Ther"},{"key":"1454_CR39","doi-asserted-by":"publisher","first-page":"631","DOI":"10.55563\/clinexprheumatol\/44kaji","volume":"39","author":"Y Kondo","year":"2021","unstructured":"Kondo\u00a0Y, Kaneko\u00a0Y, Takei\u00a0H et al (2021) COVID-19 shares clinical features with anti-melanoma differentiation-associated protein 5 positive dermatomyositis and adult still\u2019s disease. Clin Exp Rheumatol 39:631\u2013638","journal-title":"Clin Exp Rheumatol"},{"key":"1454_CR40","first-page":"638","volume":"31","author":"KT Kozu","year":"2013","unstructured":"Kozu\u00a0KT, Silva\u00a0CA, Bonfa\u00a0E et\u00a0al (2013) Dyslipidaemia in juvenile dermatomyositis: the role of disease activity. Clin Exp Rheumatol 31:638\u2013644","journal-title":"Clin Exp Rheumatol"},{"key":"1454_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11926-020-00974-9","volume":"23","author":"O Kul Cinar","year":"2021","unstructured":"Kul Cinar\u00a0O, Papadopoulou\u00a0C, Pilkington\u00a0CA (2021) Treatment of Calcinosis in juvenile dermatomyositis. Curr Rheumatol Rep 23:13","journal-title":"Curr Rheumatol Rep"},{"key":"1454_CR42","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1136\/ard.2011.153718","volume":"70","author":"CG Lam","year":"2011","unstructured":"Lam\u00a0CG, Manlhiot\u00a0C, Pullenayegum\u00a0EM et\u00a0al (2011) Efficacy of intravenous Ig therapy in juvenile dermatomyositis. Ann Rheum Dis 70:2089\u20132094","journal-title":"Ann Rheum Dis"},{"key":"1454_CR43","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1136\/annrheumdis-2012-201483","volume":"72","author":"D Lazarevic","year":"2013","unstructured":"Lazarevic\u00a0D, Pistorio\u00a0A, Palmisani\u00a0E et\u00a0al (2013) The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Ann Rheum Dis 72:686\u2013693","journal-title":"Ann Rheum Dis"},{"key":"1454_CR44","doi-asserted-by":"publisher","first-page":"5801","DOI":"10.1093\/rheumatology\/keab116","volume":"60","author":"T Le Voyer","year":"2021","unstructured":"Le Voyer\u00a0T, Gitiaux\u00a0C, Authier\u00a0FJ et\u00a0al (2021) JAK inhibitors are effective in a\u00a0subset of patients with juvenile dermatomyositis: a\u00a0monocentric retrospective study. Rheumatol (Oxford) 60:5801\u20135808","journal-title":"Rheumatol (Oxford)"},{"key":"1454_CR45","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1093\/rheumatology\/keab601","volume":"61","author":"B Lerkvaleekul","year":"2022","unstructured":"Lerkvaleekul\u00a0B, Veldkamp\u00a0SR, van der Wal\u00a0MM et al (2022) Siglec\u20111 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment response. Rheumatology 61:2144\u20132155","journal-title":"Rheumatology"},{"key":"1454_CR46","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jmii.2022.12.007","volume":"56","author":"TW Lin","year":"2023","unstructured":"Lin\u00a0TW, Hu\u00a0YC, Chiang\u00a0BL (2023) Characterization of the biomarkers related to the clinical course and outcomes of juvenile dermatomyositis. J\u00a0Microbiol Immunol Infect 56:416\u2013423","journal-title":"J Microbiol Immunol Infect"},{"key":"1454_CR47","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/art.40320","volume":"69","author":"IE Lundberg","year":"2017","unstructured":"Lundberg\u00a0IE, Tjarnlund\u00a0A, Bottai\u00a0M et\u00a0al (2017) 2017 European league against rheumatism\/American college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol 69:2271\u20132282","journal-title":"Arthritis Rheumatol"},{"key":"1454_CR48","doi-asserted-by":"publisher","first-page":"SI48","DOI":"10.1093\/rheumatology\/keab833","volume":"61","author":"G Mamyrova","year":"2022","unstructured":"Mamyrova\u00a0G, Mcbride\u00a0E, Yao\u00a0L et\u00a0al (2022) Preliminary validation of muscle ultrasound in juvenile dermatomyositis (JDM). Rheumatol (Oxford) 61:SI48\u2013SI55","journal-title":"Rheumatol (Oxford)"},{"key":"1454_CR49","first-page":"2170","volume":"294","author":"G Mamyrova","year":"2005","unstructured":"Mamyrova\u00a0G, Rider\u00a0LG, Haagenson\u00a0L et\u00a0al (2005) Parvovirus B19 and onset of juvenile dermatomyositis. JAMA 294:2170\u20132171","journal-title":"JAMA"},{"key":"1454_CR50","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s11926-022-01076-4","volume":"24","author":"K Mclellan","year":"2022","unstructured":"Mclellan\u00a0K, Papadopoulou\u00a0C (2022) Update on biomarkers of Vasculopathy in juvenile and adult myositis. Curr Rheumatol Rep 24:227\u2013237","journal-title":"Curr Rheumatol Rep"},{"key":"1454_CR51","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/art.11122","volume":"49","author":"EP Mendez","year":"2003","unstructured":"Mendez\u00a0EP, Lipton\u00a0R, Ramsey-Goldman\u00a0R et al (2003) US incidence of juvenile dermatomyositis, 1995\u20131998: results from the national institute of arthritis and musculoskeletal and skin diseases registry. Arthritis Rheum 49:300\u2013305","journal-title":"Arthritis Rheum"},{"key":"1454_CR52","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/rheumatology\/keu289","volume":"54","author":"A Meyer","year":"2015","unstructured":"Meyer\u00a0A, Meyer\u00a0N, Schaeffer\u00a0M et\u00a0al (2015) Incidence and prevalence of inflammatory myopathies: a\u00a0systematic review. Rheumatol (Oxford) 54:50\u201363","journal-title":"Rheumatol (Oxford)"},{"key":"1454_CR53","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00393-006-0056-1","volume":"65","author":"H Michels","year":"2006","unstructured":"Michels\u00a0H, Ganser\u00a0G, Dannecker\u00a0G et\u00a0al (2006) Structural quality of rheumatology clinics for children and adolescents. Paper by a\u00a0task force of the \u201csociety of pediatric and adolescent rheumatology\u201d and of the \u201cassociation of rheumatology clinics in Germany\u201d. Z\u00a0Rheumatol 65:315\u2013322 (324\u2013316)","journal-title":"Z Rheumatol"},{"key":"1454_CR54","doi-asserted-by":"publisher","first-page":"827539","DOI":"10.3389\/fmed.2022.827539","volume":"9","author":"S Mondal","year":"2022","unstructured":"Mondal\u00a0S, Barman\u00a0P, Vignesh\u00a0P (2022) Cardiovascular abnormalities in juvenile dermatomyositis: a\u00a0scoping review for the clinical rheumatologists. Front Med (Lausanne) 9:827539","journal-title":"Front Med (Lausanne)"},{"key":"1454_CR55","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/MPH.0b013e3181bf29a2","volume":"32","author":"P Morris","year":"2010","unstructured":"Morris\u00a0P, Dare\u00a0J (2010) Juvenile dermatomyositis as a\u00a0paraneoplastic phenomenon: an update. J\u00a0Pediatr Hematol Oncol 32:189\u2013191","journal-title":"J Pediatr Hematol Oncol"},{"key":"1454_CR56","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12969-022-00723-5","volume":"20","author":"K Nishi","year":"2022","unstructured":"Nishi\u00a0K, Ogura\u00a0M, Tamai\u00a0N et al (2022) Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a\u00a0case report and literature review. Pediatr Rheumatol Online\u00a0J 20:60","journal-title":"Pediatr Rheumatol Online J"},{"key":"1454_CR57","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF00300245","volume":"14","author":"M Nishikai","year":"1994","unstructured":"Nishikai\u00a0M (1994) Coxsackievirus infection and the development of polymyositis\/dermatomyositis. Rheumatol Int 14:43\u201346","journal-title":"Rheumatol Int"},{"key":"1454_CR58","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/1471-2474-11-270","volume":"11","author":"C Omori","year":"2010","unstructured":"Omori\u00a0C, Prado\u00a0DM, Gualano\u00a0B et\u00a0al (2010) Responsiveness to exercise training in juvenile dermatomyositis: a\u00a0twin case study. BMC Musculoskelet Disord 11:270","journal-title":"BMC Musculoskelet Disord"},{"key":"1454_CR59","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s11926-996-0031-5","volume":"8","author":"LM Pachman","year":"2006","unstructured":"Pachman\u00a0LM, Boskey\u00a0AL (2006) Clinical manifestations and pathogenesis of hydroxyapatite crystal deposition in juvenile dermatomyositis. Curr Rheumatol Rep 8:236\u2013243","journal-title":"Curr Rheumatol Rep"},{"key":"1454_CR60","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12016-015-8512-9","volume":"52","author":"I Pagnini","year":"2017","unstructured":"Pagnini\u00a0I, Vitale\u00a0A, Selmi\u00a0C et\u00a0al (2017) Idiopathic inflammatory myopathies: an update on classification and treatment with special focus on juvenile forms. Clin Rev Allergy Immunol 52:34\u201344","journal-title":"Clin Rev Allergy Immunol"},{"key":"1454_CR61","first-page":"348","volume":"41","author":"JJ Paik","year":"2023","unstructured":"Paik\u00a0JJ, Lubin\u00a0G, Gromatzky\u00a0A et\u00a0al (2023) Use of janus kinase inhibitors in dermatomyositis: a\u00a0systematic literature review. Clin Exp Rheumatol 41:348\u2013358","journal-title":"Clin Exp Rheumatol"},{"key":"1454_CR62","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41584-023-00967-9","volume":"19","author":"C Papadopoulou","year":"2023","unstructured":"Papadopoulou\u00a0C, Chew\u00a0C, Wilkinson\u00a0MGL et\u00a0al (2023) Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care. Nat Rev Rheumatol 19:343\u2013362","journal-title":"Nat Rev Rheumatol"},{"key":"1454_CR63","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.amjms.2020.05.011","volume":"360","author":"R Peravali","year":"2020","unstructured":"Peravali\u00a0R, Acharya\u00a0S, Raza\u00a0SH et al (2020) Dermatomyositis developed after exposure to epstein-barr virus infection and antibiotics use. Am J Med Sci 360:402\u2013405","journal-title":"Am J Med Sci"},{"key":"1454_CR64","doi-asserted-by":"publisher","first-page":"103087","DOI":"10.1016\/j.autrev.2022.103087","volume":"21","author":"Y Piette","year":"2022","unstructured":"Piette\u00a0Y, Reynaert\u00a0V, Vanhaecke\u00a0A et\u00a0al (2022) Standardised interpretation of capillaroscopy in autoimmune idiopathic inflammatory myopathies: a\u00a0structured review on behalf of the EULAR study group on microcirculation in rheumatic diseases. Autoimmun Rev 21:103087","journal-title":"Autoimmun Rev"},{"key":"1454_CR65","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.revmed.2014.04.005","volume":"35","author":"G Pouessel","year":"2014","unstructured":"Pouessel\u00a0G, Thumerelle\u00a0C, Neve\u00a0V et\u00a0al (2014) Lung is also involved in juvenile dermatomyositis. Rev Med Interne 35:461\u2013465","journal-title":"Rev Med Interne"},{"key":"1454_CR66","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1055\/s-0041-1726014","volume":"25","author":"G Pracon","year":"2021","unstructured":"Pracon\u00a0G, Aparisi Gomez\u00a0MP, Simoni\u00a0P et\u00a0al (2021) Conventional radiography and ultrasound imaging of rheumatic diseases affecting the pediatric population. Semin Musculoskelet Radiol 25:68\u201381","journal-title":"Semin Musculoskelet Radiol"},{"key":"1454_CR67","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40478-016-0308-5","volume":"4","author":"C Preusse","year":"2016","unstructured":"Preusse\u00a0C, Allenbach\u00a0Y, Hoffmann\u00a0O et\u00a0al (2016) Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis. acta neuropathol commun 4:45","journal-title":"acta neuropathol commun"},{"key":"1454_CR68","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1136\/annrheumdis-2017-211401","volume":"76","author":"LG Rider","year":"2017","unstructured":"Rider\u00a0LG, Aggarwal\u00a0R, Pistorio\u00a0A et\u00a0al (2017) 2016 American college of rheumatology\/European league against rheumatism criteria for minimal, moderate, and major clinical response in juvenile dermatomyositis: an international myositis assessment and clinical studies group\/paediatric rheumatology international trials organisation collaborative initiative. Ann Rheum Dis 76:782\u2013791","journal-title":"Ann Rheum Dis"},{"key":"1454_CR69","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1002\/art.24904","volume":"60","author":"LG Rider","year":"2009","unstructured":"Rider\u00a0LG, Lachenbruch\u00a0PA, Monroe\u00a0JB et\u00a0al (2009) Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index. Arthritis Rheum 60:3425\u20133435","journal-title":"Arthritis Rheum"},{"key":"1454_CR70","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/MD.0b013e31829d08f9","volume":"92","author":"LG Rider","year":"2013","unstructured":"Rider\u00a0LG, Shah\u00a0M, Mamyrova\u00a0G et\u00a0al (2013) The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Med (Baltimore) 92:223\u2013243","journal-title":"Med (Baltimore)"},{"key":"1454_CR71","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/rheumatology\/ken074","volume":"47","author":"P Riley","year":"2008","unstructured":"Riley\u00a0P, Mccann\u00a0LJ, Maillard\u00a0SM et\u00a0al (2008) Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis. Rheumatol (Oxford) 47:877\u2013880","journal-title":"Rheumatol (Oxford)"},{"key":"1454_CR72","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/art.23341","volume":"59","author":"KA Rouster-Stevens","year":"2008","unstructured":"Rouster-Stevens\u00a0KA, Gursahaney\u00a0A, Ngai\u00a0KL et al (2008) Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositis. Arthritis Rheum 59:222\u2013226","journal-title":"Arthritis Rheum"},{"key":"1454_CR73","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0140-6736(15)01021-1","volume":"387","author":"N Ruperto","year":"2016","unstructured":"Ruperto\u00a0N, Pistorio\u00a0A, Oliveira\u00a0S et al (2016) Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a\u00a0randomised trial. Lancet 387:671\u2013678","journal-title":"Lancet"},{"key":"1454_CR74","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/ard.2010.131433","volume":"70","author":"H Sanner","year":"2011","unstructured":"Sanner\u00a0H, Aalokken\u00a0TM, Gran\u00a0JT et al (2011) Pulmonary outcome in juvenile dermatomyositis: a\u00a0case-control study. Ann Rheum Dis 70:86\u201391","journal-title":"Ann Rheum Dis"},{"key":"1454_CR75","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1093\/rheumatology\/keu146","volume":"53","author":"H Sanner","year":"2014","unstructured":"Sanner\u00a0H, Sjaastad\u00a0I, Flato\u00a0B (2014) Disease activity and prognostic factors in juvenile dermatomyositis: a\u00a0long-term follow-up study applying the paediatric rheumatology international trials organization criteria for inactive disease and the myositis disease activity assessment tool. Rheumatol (Oxford) 53:1578\u20131585","journal-title":"Rheumatol (Oxford)"},{"key":"1454_CR76","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2169\/internalmedicine.40.185","volume":"40","author":"M Sata","year":"2001","unstructured":"Sata\u00a0M, Nagao\u00a0Y (2001) Symposium on clinical aspects in hepatitis virus infection. 6. Hepatitis virus and extrahepatic manifestions\u2014skin, mucosa, muscle, and hematopoietic organs. Intern Med 40:185\u2013189","journal-title":"Intern Med"},{"key":"1454_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","volume":"52","author":"M Satoh","year":"2017","unstructured":"Satoh\u00a0M, Tanaka\u00a0S, Ceribelli\u00a0A et al (2017) A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clin Rev Allergy Immunol 52:1\u201319","journal-title":"Clin Rev Allergy Immunol"},{"key":"1454_CR78","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1136\/ard.2010.137968","volume":"70","author":"T Schwartz","year":"2011","unstructured":"Schwartz\u00a0T, Sanner\u00a0H, Husebye\u00a0T et al (2011) Cardiac dysfunction in juvenile dermatomyositis: a\u00a0case-control study. Ann Rheum Dis 70:766\u2013771","journal-title":"Ann Rheum Dis"},{"key":"1454_CR79","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1007\/s12098-021-03680-1","volume":"88","author":"A Sharma","year":"2021","unstructured":"Sharma\u00a0A, Bhattarai\u00a0D, Gupta\u00a0A et\u00a0al (2021) Autoantibody profile of children with juvenile dermatomyositis. Indian J Pediatr 88:1170\u20131173","journal-title":"Indian J Pediatr"},{"key":"1454_CR80","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12969-022-00785-5","volume":"21","author":"MA Sherman","year":"2023","unstructured":"Sherman\u00a0MA, Kim\u00a0H, Banschbach\u00a0K et\u00a0al (2023) Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the childhood arthritis and rheumatology research alliance. Pediatr Rheumatol Online\u00a0J 21:3","journal-title":"Pediatr Rheumatol Online J"},{"key":"1454_CR81","volume-title":"Janda Manuelle Muskelfunktionsdiagnostik: Theorie und Praxis","author":"UC Smolenski","year":"2020","unstructured":"Smolenski\u00a0UC, Buchmann\u00a0J, Beyer\u00a0L et\u00a0al (2020) Janda Manuelle Muskelfunktionsdiagnostik: Theorie und Praxis. Urban & Fischer in Elsevier"},{"key":"1454_CR82","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1055\/s-2002-34636","volume":"27","author":"M Spamer","year":"2002","unstructured":"Spamer\u00a0M (2002) Physiotherapie bei juveniler Dermatomyositis. Akt Rheumatol 27:210\u2013212","journal-title":"Akt Rheumatol"},{"key":"1454_CR83","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12969-016-0112-6","volume":"14","author":"F Speth","year":"2016","unstructured":"Speth\u00a0F, Haas\u00a0JP, Hinze\u00a0CH (2016) Treatment with high-dose recombinant human hyaluronidase-facilitated subcutaneous immune globulins in patients with juvenile dermatomyositis who are intolerant to intravenous immune globulins: a\u00a0report of 5\u00a0cases. Pediatr Rheumatol Online\u00a0J 14:52","journal-title":"Pediatr Rheumatol Online J"},{"key":"1454_CR84","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1007\/s00393-013-1203-0","volume":"72","author":"F Speth","year":"2013","unstructured":"Speth\u00a0F, Wellinghausen\u00a0N, Haas\u00a0JP (2013) Medicinal prophylaxis during intensified immunosuppression in children and adolescents : part 2. Z\u00a0Rheumatol 72:896\u2013909","journal-title":"Z Rheumatol"},{"key":"1454_CR85","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s00393-013-1200-3","volume":"72","author":"F Speth","year":"2013","unstructured":"Speth\u00a0F, Wellinghausen\u00a0N, Haas\u00a0JP (2013) Screening investigations during intensified immunosuppression in children and adolescents. Part 1. Z\u00a0Rheumatol 72:814\u2013821","journal-title":"Z Rheumatol"},{"key":"1454_CR86","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1002\/art.23960","volume":"58","author":"E Stringer","year":"2008","unstructured":"Stringer\u00a0E, Singh-Grewal\u00a0D, Feldman\u00a0BM (2008) Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features. Arthritis Rheum 58:3585\u20133592","journal-title":"Arthritis Rheum"},{"key":"1454_CR87","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/rheumatology\/34.8.732","volume":"34","author":"DP Symmons","year":"1995","unstructured":"Symmons\u00a0DP, Sills\u00a0JA, Davis\u00a0SM (1995) The incidence of juvenile dermatomyositis: results from a\u00a0nation-wide study. Br J Rheumatol 34:732\u2013736","journal-title":"Br J Rheumatol"},{"key":"1454_CR88","doi-asserted-by":"crossref","unstructured":"Thakur DN, Malhotra DK, Singh DP (2023) Post Covid juvenile dermatomyoscitis with non hodgkins lymphoma in a\u00a0child\u2014a case report. Curr Rheumatol Rev","DOI":"10.2174\/1573397119666230331083402"},{"key":"1454_CR89","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13075-018-1687-8","volume":"20","author":"EHP Van Dijkhuizen","year":"2018","unstructured":"Van Dijkhuizen\u00a0EHP, De Iorio\u00a0M, Wedderburn\u00a0LR et\u00a0al (2018) Clinical signs and symptoms in a\u00a0joint model of four disease activity parameters in juvenile dermatomyositis: a\u00a0prospective, longitudinal, multicenter cohort study. Arthritis Res Ther 20:180","journal-title":"Arthritis Res Ther"},{"key":"1454_CR90","doi-asserted-by":"publisher","first-page":"5419","DOI":"10.1093\/rheumatology\/keab089","volume":"60","author":"GC Varnier","year":"2021","unstructured":"Varnier\u00a0GC, Consolaro\u00a0A, Maillard\u00a0S et\u00a0al (2021) Comparison of treatments and outcomes of children with juvenile dermatomyositis followed at two European tertiary care referral centers. Rheumatol (Oxford) 60:5419\u20135423","journal-title":"Rheumatol (Oxford)"},{"key":"1454_CR91","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2147\/JMDH.S171095","volume":"12","author":"H Wakiguchi","year":"2019","unstructured":"Wakiguchi\u00a0H (2019) Multispecialty approach for improving outcomes in juvenile dermatomyositis. J\u00a0Multidiscip Healthc 12:387\u2013394","journal-title":"J Multidiscip Healthc"},{"key":"1454_CR92","doi-asserted-by":"publisher","first-page":"5607473","DOI":"10.1155\/2023\/5607473","volume":"2023","author":"C Wang","year":"2023","unstructured":"Wang\u00a0C, Hou\u00a0J, Lai\u00a0J et al (2023) Correlation between CT score and KL-6: a\u00a0severity assessing in juvenile dermatomyositis associated interstitial lung disease. Can Respir\u00a0J 2023:5607473","journal-title":"Can Respir J"},{"key":"1454_CR93","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/art.40881","volume":"71","author":"J Wienke","year":"2019","unstructured":"Wienke\u00a0J, Bellutti Enders\u00a0F, Lim\u00a0J et al (2019) Galectin\u20119 and CXCL10 as biomarkers for disease activity in juvenile dermatomyositis: a\u00a0longitudinal cohort study and multicohort validation. Arthritis Rheumatol 71:1377\u20131390","journal-title":"Arthritis Rheumatol"},{"key":"1454_CR94","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.3389\/fimmu.2018.02951","volume":"9","author":"J Wienke","year":"2018","unstructured":"Wienke\u00a0J, Deakin\u00a0CT, Wedderburn\u00a0LR et\u00a0al (2018) Systemic and tissue inflammation in juvenile dermatomyositis: from pathogenesis to the quest for monitoring tools. Front Immunol 9:2951","journal-title":"Front Immunol"},{"key":"1454_CR95","first-page":"194","volume":"59","author":"MGL Wilkinson","year":"2020","unstructured":"Wilkinson\u00a0MGL, Radziszewska\u00a0A, Wincup\u00a0C et\u00a0al (2020) Using peripheral blood immune signatures to stratify patients with adult and juvenile inflammatory myopathies. Rheumatol (Oxford) 59:194\u2013204","journal-title":"Rheumatol (Oxford)"},{"key":"1454_CR96","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12969-020-00486-x","volume":"19","author":"Y Xu","year":"2021","unstructured":"Xu\u00a0Y, Ma\u00a0X, Zhou\u00a0Z et al (2021) Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a\u00a0review of the literature. Pediatr Rheumatol Online\u00a0J 19:2","journal-title":"Pediatr Rheumatol Online J"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-023-01454-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-023-01454-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-023-01454-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T13:04:20Z","timestamp":1707224660000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-023-01454-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,29]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1454"],"URL":"https:\/\/doi.org\/10.1007\/s00393-023-01454-y","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,29]]},"assertion":[{"value":"15 October 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"I.\u00a0Georgi, M.\u00a0Georgi und J.-P.\u00a0Haas geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}